• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

N Engl J Med 2013 Nov 14;369(20):1877-80

Expediting drug development--the FDA's new "breakthrough therapy" designation.

Sherman RE, Li J, Shapley S, Robb M, Woodcock J

Abstract

The FDA's new "breakthrough therapy" designation for investigational drugs adds to the agency's portfolio of expedited programs for serious conditions. The designation requires preliminary clinical evidence demonstrating substantial improvement over existing therapies.


Category: Journal Article, Editorial
PubMed ID: #24224621 DOI: 10.1056/NEJMp1311439
Includes FDA Authors from Scientific Area(s): Drugs
Entry Created: 2013-11-16 Entry Last Modified: 2014-03-01
Feedback
-
-